Recursion Pharmaceuticals, Inc. (RXRX)
USD 6.22
(-12.71%)
USD 6.22
(-12.71%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -287.78 Million | -83.52 Million | -158.61 Million | -45.39 Million | -57.04 Million |
| Net Income | -328.06 Million | -239.47 Million | -186.47 Million | -87 Million | -61.87 Million |
| Depreciation & Amortization | 32.46 Million | 11.75 Million | 8.4 Million | 4.44 Million | 2.48 Million |
| Deferred income taxes | -364.69 Million | - | 827 Thousand | 1.75 Million | 1.05 Million |
| Stock-based compensation | 53.5 Million | 27.9 Million | 14.84 Million | 4.29 Million | 1.38 Million |
| Change in working capital | -50.25 Million | 104.92 Million | -306 Thousand | 30.83 Million | 408 Thousand |
| Other non-cash items | 369.27 Million | 11.36 Million | 4.09 Million | 282 Thousand | -499 Thousand |
| Investing Cash Flow | -10.22 Million | 193.24 Million | -271.74 Million | -8.74 Million | -3.91 Million |
| Investments in PPE | -12.55 Million | -37.35 Million | -39.79 Million | -6.73 Million | -3.91 Million |
| Acquisitions | 1.84 Million | - | 231.94 Million | -2.6 Million | - |
| Investment purchases | 597 Thousand | - | -301.13 Million | - | - |
| Sales/Maturities of investments | 480 Thousand | 230.6 Million | 69.19 Million | - | - |
| Other Investing Activities | -597 Thousand | 230.3 Million | -231.94 Million | 595 Thousand | - |
| Financing Cash Flow | 140.13 Million | 154.34 Million | 458.54 Million | 246.13 Million | 120.41 Million |
| Debt repayment | -766 Thousand | -90 Thousand | -12.79 Million | -77 Thousand | -11.18 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 140.89 Million | 143.71 Million | 462.9 Million | 239.81 Million | 119.7 Million |
| Other Financing Activities | 140.13 Million | 10.72 Million | 8.43 Million | 6.4 Million | 11.88 Million |
| Accounts receivables | -7.75 Million | -2000.00 | 114 Thousand | -5000.00 | -27 Thousand |
| Accounts payables | -987 Thousand | 1.76 Million | 1.74 Million | -185 Thousand | -340 Thousand |
| Inventory | - | 2000.00 | 7.83 Million | 4.35 Million | - |
| Other working capital | -41.51 Million | 103.15 Million | -10 Million | 26.66 Million | 775 Thousand |
| Cash at beginning of period | 551.19 Million | 295.34 Million | 267.16 Million | 75.17 Million | 15.71 Million |
| Cash at end of period | 394.79 Million | 559.11 Million | 295.34 Million | 267.16 Million | 75.17 Million |
| Capital Expenditure | -12.55 Million | -37.35 Million | -39.79 Million | -6.73 Million | -3.91 Million |
| Effect of forex changes on cash | 188 Thousand | -307 Thousand | - | - | - |
| Net cash flow / Change in cash | -156.39 Million | 263.76 Million | 28.18 Million | 191.99 Million | 59.45 Million |
| Free Cash Flow | -300.33 Million | -120.88 Million | -198.41 Million | -52.13 Million | -60.95 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -97.54 Million | -91.37 Million | -92.99 Million | -328.06 Million | -93.01 Million | -76.72 Million |
| Depreciation & Amortization | 8 Million | 7.4 Million | 15.61 Million | 32.46 Million | 7.57 Million | 5.54 Million |
| Deferred income taxes | - | - | -54.05 Million | -364.69 Million | 19 Thousand | - |
| Stock-based compensation | 16.52 Million | 16.12 Million | 16.08 Million | 53.5 Million | 16.79 Million | 11.81 Million |
| Change in working capital | -10.26 Million | -36.45 Million | -11.27 Million | -50.25 Million | -4.46 Million | -10.12 Million |
| Other non-cash items | 34.19 Million | 32.79 Million | 52.54 Million | 369.27 Million | 170 Thousand | 2.02 Million |
| Investing Cash Flow | -4.18 Million | -6.65 Million | -2.48 Million | -10.22 Million | -347 Thousand | -2.05 Million |
| Investments in PPE | -4.18 Million | -6.65 Million | -2.41 Million | -12.55 Million | -827 Thousand | -3.96 Million |
| Acquisitions | - | - | -71 Thousand | 1.84 Million | - | 1.91 Million |
| Investment purchases | - | - | - | 597 Thousand | - | - |
| Sales/Maturities of investments | - | - | - | 480 Thousand | 480 Thousand | - |
| Other Investing Activities | -3 Million | - | -350 Thousand | -597 Thousand | 398 Thousand | - |
| Financing Cash Flow | 263.12 Million | 13.89 Million | 80.65 Million | 140.13 Million | 53.76 Million | 3.78 Million |
| Debt repayment | -26 Thousand | -26 Thousand | -694 Thousand | -766 Thousand | -24 Thousand | -24 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 263.14 Million | 13.92 Million | 81.35 Million | 140.89 Million | 53.78 Million | 3.81 Million |
| Other Financing Activities | 263.14 Million | 13.92 Million | 81.35 Million | 140.13 Million | 53.76 Million | 3.78 Million |
| Accounts receivables | 736 Thousand | -1.04 Million | -6.42 Million | -7.75 Million | -203 Thousand | -814 Thousand |
| Accounts payables | -1.34 Million | 1.16 Million | -317 Thousand | -987 Thousand | 2.18 Million | -2.51 Million |
| Inventory | - | - | -1.33 Million | - | 203 Thousand | 814 Thousand |
| Other working capital | -9.65 Million | -36.57 Million | -4.53 Million | -41.51 Million | -6.64 Million | -7.6 Million |
| Cash at beginning of period | 299.52 Million | 394.79 Million | 389.57 Million | 551.19 Million | 416.82 Million | 482.37 Million |
| Cash at end of period | 476.12 Million | 299.52 Million | 394.79 Million | 394.79 Million | 397.2 Million | 416.82 Million |
| Capital Expenditure | -4.18 Million | -6.65 Million | -2.41 Million | -12.55 Million | -827 Thousand | -3.96 Million |
| Effect of forex changes on cash | -118 Thousand | -219 Thousand | 124 Thousand | 188 Thousand | -115 Thousand | 181 Thousand |
| Net cash flow / Change in cash | 176.6 Million | -95.27 Million | 5.21 Million | -156.39 Million | -19.61 Million | -65.55 Million |
| Free Cash Flow | -86.4 Million | -108.95 Million | -76.49 Million | -300.33 Million | -73.74 Million | -71.43 Million |
603606
MANAPPURAM
287410
688272
005965
CIBEY